Concurrent Chemoradiotherapy as an Adjuvant Treatment of Primary Central Nervous System Neuroblastoma

Perm J. 2022 Jun 29;26(2):166-171. doi: 10.7812/TPP/21.147. Epub 2022 Jun 17.

Abstract

Primary central nervous system neuroblastoma is a rare malignant embryonal tumor. With only few cases reported in the literature, data on regardingthe diagnosis and management of these tumors are limited. We reported a case of primary cerebral neuroblastoma in a 20-year-old woman complaining of progressive headaches. The patient underwent subtotal tumor resection and adjuvant concurrent chemoradiotherapy. The prescription dose was 54 Gy. She remained free of recurrence for 14 months after the end of radiotherapy treatment.

Keywords: central nervous system tumor; management; neuroblastoma; radiotherapy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • Central Nervous System
  • Chemoradiotherapy
  • Female
  • Humans
  • Neuroblastoma* / therapy
  • Young Adult